Lithium and Canagliflozin Interaction

Drug interaction information between Lithium and Canagliflozin.

Lithium and Canagliflozin have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Lithium and Canagliflozin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Lithium

Mood Stabilizer

Drug B

Canagliflozin

SGLT2 Inhibitor

How They Interact

Canagliflozin can cause the body to remove lithium more quickly, which lowers the amount of lithium in your blood.

FDA Label Information

Lithium Clinical Impact: Concomitant use of an SGLT2 inhibitor with lithium may decrease serum lithium concentrations. Intervention: Monitor serum lithium concentration more frequently during INVOKANA initiation and dosage changes.

Canagliflozin Also Interacts With

View all Canagliflozin interactions →

Frequently Asked Questions

What SPL severity band is on file for Lithium + Canagliflozin?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Lithium has 90 labeled pairs on file vs Canagliflozin's 5. In the minor band specifically: Lithium has 65 (also Aripiprazole, Asenapine, Candesartan, Celecoxib); Canagliflozin has 2 (also Digoxin).

What mechanism field is on file for Lithium and Canagliflozin?

Canagliflozin can cause the body to remove lithium more quickly, which lowers the amount of lithium in your blood.

Lithium carries more major-labeled pairs than Canagliflozin

SPL source-record counts only. This page's band is minor · classes on file: Lithium (Mood Stabilizer); Canagliflozin (SGLT2 Inhibitor).

Lithium has 2 major-labeled pairs vs Canagliflozin's 0. This page itself is in the minor band, not the major band.

Lithium

2 major · 23 moderate · 65 minor · 90 total

Canagliflozin

0 major · 3 moderate · 2 minor · 5 total

  • Other minor peers for Canagliflozin
  • Digoxin

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.